Incorporation of serum albumin and/or hypoalbuminemia into clinical outcome predictive models is not a novel phenomenon, as several of these prognostic indices already rely on patient albumin status to estimate survival and other measures of morbidity (Gradel, 2023). Here, ALB is linked to Hypoalbuminemia.